文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

870 例鼻咽癌区域淋巴结转移分布及调强放疗个体化选择性预防照射的建议。

Distribution of regional lymph nodes metastasis in 870 cases of nasopharyngeal carcinoma and the suggestions for individualized elective prophylactic neck irradiation with intensity-modulated radiotherapy.

机构信息

Department of Radiotherapy, Peking University Cancer Hospital Yunnan, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Yunnan Cancer Center, Kunming Yunnan, P.R. China.

Department of Radiation Oncology, Hunan Cancer Hospital & the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha Hunan, P.R. China.

出版信息

Cancer Med. 2024 Feb;13(3):e6723. doi: 10.1002/cam4.6723. Epub 2023 Dec 29.


DOI:10.1002/cam4.6723
PMID:38156901
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10905225/
Abstract

PURPOSE: To explore the feasibility of individualized elective prophylactic neck irradiation (iEPNI) for optimizing current approach by investigating metastatic lymph nodes (LNs) distribution in nasopharyngeal carcinoma (NPC). MATERIALS AND METHODS: Records of 870 NPC patients without distant metastasis in Hunan Cancer Hospital from January 2019 to December 2019 were reviewed. LNs' locations were identified based on the 2013 guidelines. The intra-regional lymphatic drainage (IRLD) areas included Station 1st (level VIIa and II), Station 2nd (level III and Va), and Station 3rd (level IV, Vb, and Vc). Other levels were categorized as extra-regional areas. RESULTS: Among the 870 patients, 94.5% cases exhibited LNs metastasis, including unilateral metastasis in 198 patients and bilateral metastasis in 624 patients. In the whole cohort, the most common involved IRLD areas were level IIb (87.1%), VIIa (80.0%), IIa (61.8%), Va (30.6%), IV (21.4%), Vb (8.9%), and Vc (1.1%). Besides, rates of LNs metastasis in Station 1st, 2nd, and 3rd were 94.3%, 61.1%, and 22.9%, respectively. Only four patients (4, 0.5%) revealed skipping metastasis among the three stations. CONCLUSIONS: Lymph node metastasis follows an organized pattern from Station 1st to 3rd with scarce skipping metastasis. A potential iEPNI strategy of prophylactic neck irradiation to the ipsilateral latter node-negative station appears promising in NPC patients. Further prospective investigations are warranted to validate the approach.

摘要

目的:通过研究鼻咽癌(NPC)转移淋巴结(LNs)的分布,探讨个体化选择性预防性颈部照射(iEPNI)优化当前治疗策略的可行性。

材料与方法:回顾 2019 年 1 月至 12 月在湖南省肿瘤医院就诊的 870 例无远处转移的 NPC 患者的病历资料。基于 2013 年的指南确定 LNs 的位置。区域性淋巴结引流(IRLD)区域包括第 1 站(水平 VIIa 和 II)、第 2 站(水平 III 和 Va)和第 3 站(水平 IV、Vb 和 Vc)。其他水平被归类为区域外区域。

结果:在 870 例患者中,94.5%的患者存在 LNs 转移,其中 198 例为单侧转移,624 例为双侧转移。在整个队列中,最常见的累及 IRLD 区域为水平 IIb(87.1%)、VIIa(80.0%)、IIa(61.8%)、Va(30.6%)、IV(21.4%)、Vb(8.9%)和 Vc(1.1%)。此外,第 1 站、第 2 站和第 3 站的 LNs 转移率分别为 94.3%、61.1%和 22.9%。三个站中仅有 4 例(4,0.5%)存在跳跃性转移。

结论:淋巴结转移呈从第 1 站到第 3 站的有序模式,跳跃性转移很少见。对于 NPC 患者,采用同侧无后者淋巴结阴性站的个体化选择性预防性颈部照射(iEPNI)策略可能具有广阔的应用前景。需要进一步的前瞻性研究来验证该方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc15/10905225/5592ac0e3046/CAM4-13-e6723-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc15/10905225/0470b4dcfd6b/CAM4-13-e6723-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc15/10905225/5592ac0e3046/CAM4-13-e6723-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc15/10905225/0470b4dcfd6b/CAM4-13-e6723-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc15/10905225/5592ac0e3046/CAM4-13-e6723-g001.jpg

相似文献

[1]
Distribution of regional lymph nodes metastasis in 870 cases of nasopharyngeal carcinoma and the suggestions for individualized elective prophylactic neck irradiation with intensity-modulated radiotherapy.

Cancer Med. 2024-2

[2]
Distribution of regional lymph lode metastasis in unilateral nasopharyngeal carcinoma and the suggestions for selective prophylactic irradiation with intensity-modulated radiotherapy.

Cancer Med. 2023-11

[3]
Risk factors and distribution features of level IB lymph nodes metastasis in nasopharyngeal carcinoma.

Auris Nasus Larynx. 2019-6

[4]
Distribution pattern and prognosis of metastatic lymph nodes in cervical posterior to level V in nasopharyngeal carcinoma patients.

BMC Cancer. 2020-7-17

[5]
Delineation of reduced CTV2 on the basis of the characteristics and distribution of cervical lymph node metastasis in nasopharyngeal carcinoma.

BMC Cancer. 2025-1-25

[6]
Comparative study on prophylactic irradiation to the whole neck and to the upper neck for patients with neck lymph node-negative nasopharyngeal carcinoma.

Head Neck. 2014-5

[7]
The feasibility analysis of omission of elective irradiation to level IB lymph nodes in low-risk nasopharyngeal carcinoma based on the 2013 updated consensus guideline for neck nodal levels.

Radiat Oncol. 2017-8-18

[8]
Treatment outcome of nasopharyngeal carcinoma with retropharyngeal lymph nodes metastasis only and the feasibility of elective neck irradiation.

Oral Oncol. 2012-5-24

[9]
Investigation of the feasibility of elective irradiation to neck level Ib using intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma: a retrospective analysis.

BMC Cancer. 2015-10-15

[10]
Correlation analysis of neck node levels in 960 cases of Nasopharyngeal carcinoma (NPC).

Radiother Oncol. 2021-8

引用本文的文献

[1]
Predictive Effect of Prognostic Nutritional Index on Lymph Node Regression Rate in Patients with Locally Advanced Nasopharyngeal Carcinoma Undergoing Concurrent Chemoradiotherapy.

Technol Cancer Res Treat. 2025

[2]
A prognostic nomogram based on lymph node skipping metastases in esophageal squamous cell carcinoma.

J Thorac Dis. 2025-4-30

[3]
PTEN as a prognostic factor for radiotherapy plus immunotherapy response in nasopharyngeal carcinoma.

J Nanobiotechnology. 2025-4-21

[4]
A combination of Dihydroartemisinin and Venetoclax enhances antitumor effect in AML via C-MYC/BCL-XL/MCL-1 triple targeting.

Discov Oncol. 2025-4-9

[5]
High Expression of GPR183 Predicts Poor Survival in Cytogenetically Normal Acute Myeloid Leukemia.

Biochem Genet. 2025-1-16

[6]
Long non-coding RNAs in cancer: multifaceted roles and potential targets for immunotherapy.

Mol Cell Biochem. 2024-12

本文引用的文献

[1]
Upper-neck irradiation versus standard whole-neck irradiation in nasopharyngeal carcinoma: A systematic review and meta-analysis.

Tumori. 2023-12

[2]
Lower-Neck Sparing Using Proton Therapy in Patients with Uninvolved Neck Nasopharyngeal Carcinoma: Is It Safe?

J Clin Med. 2022-6-9

[3]
Characteristics of locoregional extension of unilateral nasopharyngeal carcinoma and suggestions for clinical target volume delineation.

Radiat Oncol. 2022-3-12

[4]
Elective upper-neck versus whole-neck irradiation of the uninvolved neck in patients with nasopharyngeal carcinoma: an open-label, non-inferiority, multicentre, randomised phase 3 trial.

Lancet Oncol. 2022-4

[5]
The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma.

Cancer Commun (Lond). 2021-11

[6]
Correlation analysis of neck node levels in 960 cases of Nasopharyngeal carcinoma (NPC).

Radiother Oncol. 2021-8

[7]
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.

J Natl Compr Canc Netw. 2020-7

[8]
Oncologic outcomes of IMRT versus CRT for nasopharyngeal carcinoma: A meta-analysis.

Medicine (Baltimore). 2019-6

[9]
Nasopharyngeal carcinoma.

Lancet. 2019-6-6

[10]
Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: A report of 3328 patients (HKNPCSG 1301 study).

Oral Oncol. 2017-12-12

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索